ATLANTA, April 4, 2019 /PRNewswire-PRWeb/ -- World leading nutraceutical manufacturer Pharm Origins has announced a 2019 release date for the highly sought after Sirtuin 1, youth gene activating sublingual.
Sirtuin 1 has been precisely formulated, delivering potent extracted Trans–Resveratrol to the human body for the purposes of youth gene activation and circulation enhancement.
MIT has proven in previous studies that extremely potent dosages of Trans-Resveratrol naturally activates the SIRT 1 "youth gene" in humans of any age.
They have cited specific benefits for those dealing with type 2 diabetes and the associated circulation issues.
Type two diabetes affects over one hundred million Americans.
"When it comes to the powerful circulation boosting effects of the SIRT 1 'youth gene,' we have been closely following the body of research that MIT has been building over the past twenty years," said Pharm Origins spokesperson and natural health expert, Clint Winters.
"We believe every human on earth wants to look and feel their best, and the circulation boosting effects of Sirtuin 1 is set to give millions the 'youthful' feeling they have longed to have for years."
The Sirtuin 1 sublingual is 100% naturally extracted Trans-Resveratrol, originating from the purest source on earth, rare Japanese Fallopia Japonica.
"For the development of Sirtuin 1, we had to utilize our patent pending Ethyl Extraction system to extract the purest trans resveratrol on earth. This ensures our formula is strong enough for youth gene activation," said Travis Shoaf Director of Pharm Origins Manufacturing division.
He went on to say, "From our research, Sirtuin 1 is the strongest source of Trans-Resveratrol and subsequently the strongest youth gene activator ever released in the world."
When SIRT 1 is activated, the human body is able to release Sirtuin proteins, the building blocks of the human vascular system. This allows for enhanced circulation and dramatic anti-aging effects in humans of all ages.
This is specifically important for those dealing with suppressed circulation due to age or type two Diabetes.
Sirtuin 1 will be released privately to the current Pharm Origins customer base in early 2019, with worldwide release scheduled later in the year.
This will the first natural "youth gene" activator every released in the United States.
Pharm Origins was founded in 2011 and is an FDA registered dietary supplement formulator and manufacturer located in Atlanta, GA.
SOURCE Pharm Origins
Share this article